JP2009536934A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009536934A5 JP2009536934A5 JP2009508382A JP2009508382A JP2009536934A5 JP 2009536934 A5 JP2009536934 A5 JP 2009536934A5 JP 2009508382 A JP2009508382 A JP 2009508382A JP 2009508382 A JP2009508382 A JP 2009508382A JP 2009536934 A5 JP2009536934 A5 JP 2009536934A5
- Authority
- JP
- Japan
- Prior art keywords
- oxymacbecin
- compound
- analog
- post
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0609117.7A GB0609117D0 (en) | 2006-05-09 | 2006-05-09 | Novel compounds |
| PCT/EP2007/054473 WO2007128827A1 (en) | 2006-05-09 | 2007-05-09 | 17-oxymacbecin derivatives and their use in the treatment of cancer and/or b-cell malignancies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009536934A JP2009536934A (ja) | 2009-10-22 |
| JP2009536934A5 true JP2009536934A5 (https=) | 2010-05-27 |
Family
ID=36637122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009508382A Abandoned JP2009536934A (ja) | 2006-05-09 | 2007-05-09 | １７−オキシマクベシン誘導体並びに癌及び／又はｂ−細胞性悪性疾患の治療におけるそれらの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20100068203A1 (https=) |
| EP (1) | EP1940798A1 (https=) |
| JP (1) | JP2009536934A (https=) |
| KR (1) | KR20090005377A (https=) |
| CN (1) | CN101437802A (https=) |
| AU (1) | AU2007247119A1 (https=) |
| BR (1) | BRPI0711092A2 (https=) |
| CA (1) | CA2651557A1 (https=) |
| GB (1) | GB0609117D0 (https=) |
| MX (1) | MX2008014279A (https=) |
| WO (1) | WO2007128827A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0718562A2 (pt) * | 2006-11-09 | 2014-04-08 | Biotica Tech Ltd | Composto, processo para preparar e para gerar análogo de macbecina, análogo de macbecina, composição farmacêutica, uso do análogo de macbecina, e, cepa engenheirada. |
| US9967590B2 (en) | 2008-04-10 | 2018-05-08 | Qualcomm Incorporated | Rate-distortion defined interpolation for video coding based on fixed filter or adaptive filter |
| AR077405A1 (es) | 2009-07-10 | 2011-08-24 | Sanofi Aventis | Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer |
| FR2949467B1 (fr) | 2009-09-03 | 2011-11-25 | Sanofi Aventis | Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation |
| CN110999828A (zh) * | 2019-12-19 | 2020-04-14 | 上海海洋大学 | 改变鱼类体色分布模式的方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5360694A (en) * | 1992-10-14 | 1994-05-09 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Tumoricidal activity of benzoquinonoid ansamycins against prostate cancer and primitive neural malignancies |
| EP0828418A4 (en) * | 1995-05-02 | 2000-03-29 | Univ California | INDUCTION OF THERMOTOLERANCE WITH BENZOCHINOIDS ANSAMYCINES |
-
2006
- 2006-05-09 GB GBGB0609117.7A patent/GB0609117D0/en not_active Ceased
-
2007
- 2007-05-09 MX MX2008014279A patent/MX2008014279A/es unknown
- 2007-05-09 WO PCT/EP2007/054473 patent/WO2007128827A1/en not_active Ceased
- 2007-05-09 CA CA002651557A patent/CA2651557A1/en not_active Abandoned
- 2007-05-09 US US12/296,537 patent/US20100068203A1/en not_active Abandoned
- 2007-05-09 EP EP07728925A patent/EP1940798A1/en not_active Withdrawn
- 2007-05-09 AU AU2007247119A patent/AU2007247119A1/en not_active Abandoned
- 2007-05-09 BR BRPI0711092-8A patent/BRPI0711092A2/pt not_active IP Right Cessation
- 2007-05-09 JP JP2009508382A patent/JP2009536934A/ja not_active Abandoned
- 2007-05-09 CN CNA2007800165888A patent/CN101437802A/zh active Pending
- 2007-05-09 KR KR1020087027546A patent/KR20090005377A/ko not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102820455B1 (ko) | Shp2 활성 억제용 화합물의 제조 방법 | |
| TW202313616A (zh) | 新型雙環化合物及其用途 | |
| EP2694072B1 (en) | Combination of akt inhibitor compound and abiraterone for use in therapeutic treatments | |
| TWI464172B (zh) | 吡唑并－喹唑啉化合物 | |
| WO2020068867A1 (en) | Quinazoline derivatives as tyrosine kinase inhibitor, compositions, methods of making them and their use | |
| JP2021169520A (ja) | Ｐｒｍｔ５阻害剤として使用するための新規な６−６二環式芳香環置換ヌクレオシド類似体 | |
| JP2022501430A (ja) | Ｓｒｃホモロジー−２ホスファターゼ阻害剤としての三置換ヘテロアリール誘導体 | |
| KR102043803B1 (ko) | 항-CD20 항체와 Bcl-2 억제제 및 MDM2 억제제의 병용 요법 | |
| KR20230113285A (ko) | N-아세틸갈락토사민(GAlNAc)-유래 화합물 및 올리고뉴클레오티드 | |
| JP7741142B2 (ja) | ある種のプラジエノライド化合物及び使用方法 | |
| WO2013059944A1 (en) | Epigenetic regulators and uses thereof | |
| JP2009536934A5 (https=) | ||
| AU2020343329C1 (en) | Methods of treatment | |
| JP2009536181A5 (https=) | ||
| JP7223684B2 (ja) | ピラゾロ［３，４－ｄ］ピリミジン化合物を用いた抗腫瘍効果増強剤 | |
| WO2020186196A1 (en) | Trisubstituted pyrazolo [1,5-a] pyrimidine compounds as cdk7 inhibitors | |
| AU2020410900B2 (en) | Compound used as RET kinase inhibitor and application thereof | |
| KR102779693B1 (ko) | Mll1 억제제 및 항암제 | |
| JP7636322B2 (ja) | 癌を処置するためのマドラシン誘導体化合物、組成物およびこれらの使用 | |
| JP2010509306A5 (https=) | ||
| AU2020247812B2 (en) | Muscarinic acetylcholine receptor subtype 4 antagonists in the treatment of anemia | |
| US20250188059A1 (en) | Novel compound and use thereof for inhibiting checkpoint kinase 2 | |
| CN120379671A (zh) | 用于治疗癌症的化合物 | |
| JP2016504394A (ja) | 抗がん剤としてのゲム−ジふっ化ｃ−グリコシド化合物 | |
| WO2025064744A1 (en) | Tyra-300 (5-[(1r)-1-(3,5-dichloro-4-pyridyl)ethoxy]-3-[6-(2-methylsulfonyl-2,6-diazaspiro[3.3]heptan-6-yl)-3-pyridyl]-1h-indazole ) in combination with a pd-1 or pd-l1 antagonist for use in the treatment of cancer |